Renzenbrink & Partner advises IK on the acquisition of Ondal Group from Capvis

4 December 2019

Renzenbrink & Partner advises funds advised by IK Investment Partners (Mid Cap VIII) on the acquisition of Ondal Group from Capvis. The completion of the transaction is subject to approval by the antitrust authorities. The parties have agreed not to disclose financial terms of the transaction.

Founded in 1945, Ondal has grown to become the world’s leading supplier of medical pendant systems up to 1,000 kg. With its innovative and broad product portfolio applied in settings such as operating rooms, intensive care units as well as diagnostic and imaging rooms, Ondal sets the global quality standard for medical pendant systems in terms of reliability, functionality and usability. Headquartered in Hünfeld, Germany, Ondal operates three production sites in Germany, the US and China, employing over 500 people.

Capvis acquired Ondal in 2012. Since then, Ondal’s product platform has been successfully expanded through substantial investments in innovation strengthened by numerous new patents.

The Renzenbrink & Partner team has advised IK Investment Partners on all corporate and tax aspects of the transaction. The team consisted of Dr Ulf Renzenbrink (Private Equity, leading partner), Marc H. Kotyrba (Tax), Dr Andreas Stoll (Private Equity) and Dr Gunnar L. Schmüser (Finance) as well as the associates Dr Niels Maier, Martin Aisenbrey and Antonia Neumerkel.